NVOXDefiance Daily Target 2X Long NVO ETF
Seeks daily investment results of 200% the daily percentage change in the share price of NVO.
By Defiance ETFs LLC · Launched 2024
Annual Cost
1.31%
#5,752 of 6,040 · expensive
Fund Size
$35M
#4,103 of 6,040 · small
Return (1Y)
-59.1%
Track Record
1 year
#3,890 of 6,040 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$3,930-60.7%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityStrategy
Leveraged
Holdings
By weightConcentration
single-stock exposure — holdings shown are derivatives collateral, not the fund's position
TREASURY BILL
18.0%
N/A
10.1%
First American Government Obli
9.8%
N/A
3.8%
N/A
2.9%
N/A
2.8%
N/A
2.6%
N/A
2.3%
N/A
1.7%
Asset allocation
Other
194.4%
Stocks
24.0%
By sector
Healthcare
100.0%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
92.4%High
Year-on-year price swings
Max drawdown
-94.5%Severe
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks daily investment results of 200% the daily percentage change in the share price of NVO.
- Strategy
- Actively managed ETF aiming for 200% daily exposure to the share price of NVO using derivatives like swaps and options. Concentrated in the pharmaceutical industry.
- Inception date
- December 2, 2024
- Fund family
- Defiance ETFs LLC
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save NVOX to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-18